The trinity of COVID-19: immunity, inflammation and intervention

Cited by (1,002)

Items 401–500 of 1,002

1. Prevalence of opportunistic invasive aspergillosis in COVID‐19 patients with severe pneumonia
   Gonzalo Segrelles‐Calvo, Glauber Ribeiro de Sousa Araújo, Estefanía Llopis Pastor, Javier Carrillo, Marta Hernández‐Hernández, Laura Rey, Nestor Rodríguez Melean, Inés Escribano, Esther Garcés Antón, Celia Zamarro et al. · 2020 · Mycoses
2. Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19
   Shama Ahmad, Shajer Manzoor, Sazia Siddiqui, Nithya Mariappan, Iram Zafar, Aamir Ahmad, Aftab M. Ahmad · 2021 · Seminars in Cancer Biology
3. Xuanfei Baidu Decoction protects against macrophages induced inflammation and pulmonary fibrosis via inhibiting IL-6/STAT3 signaling pathway
   Yuying Wang, Xiaoqing Sang, Rui Shao, Honglin Qin, Xuanhao Chen, Zhifeng Xue, Lin Li, Yu Wang, Yan Zhu, Yanxu Chang et al. · 2021 · Journal of Ethnopharmacology
4. Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey
   Raffaele Izzo, Valentina Trimarco, Pasquale Mone, Teresita Aloè, Massimo Capra Marzani, Antonio Diana, Giovanni Fazio, Mario Mallardo, Mauro Maniscalco, Giuseppe Marazzi et al. · 2022 · Pharmacological Research
5. COVID-19: a hypothesis regarding the ventilation-perfusion mismatch
   Mario G. Santamarina, Dominique Boisier Riscal, Roberto Contreras, Martiniano Baque, Mariano M. Volpacchio, Ignacio Beddings · 2020 · Critical Care
6. A multiple-hit hypothesis involving reactive oxygen species and myeloperoxidase explains clinical deterioration and fatality in COVID-19
   Goud, Pravin T, Bai, David, Abu-Soud, Husam M · 2021 · International Journal of Biological Sciences
7. Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections
   Simone A. Thair, Yudong D. He, Yehudit Hasin-Brumshtein, Suraj Sakaram, Rushika Pandya, Jiaying Toh, David Rawling, Melissa Remmel, Sabrina Coyle, George Ν. Dalekos et al. · 2020 · iScience
8. Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases
   To Sing Fung, Ding Xiang Liu · 2021 · Annual Review of Microbiology
9. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)
   Amir Hossein Norooznezhad, Kamran Mansouri · 2021 · Microvascular Research
10. Cellular Nanosponges for Biological Neutralization
    Shuyan Wang, Dan Wang, Yaou Duan, Zhidong Zhou, Weiwei Gao, Liangfang Zhang · 2021 · Advanced Materials
11. Ocular manifestations of coronavirus disease 2019
    Başak Bostancı Ceran, Serdar Özateş · 2020 · Graefe s Archive for Clinical and Experimental Ophthalmology
12. Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review
    Suwen Hu, Songwei Jiang, Qi Xiang, Renren Bai, Xiang‐Yang Ye, Tian Xie · 2021 · Drug Development Research
13. Propolis antiviral and immunomodulatory activity: a review and perspectives for COVID-19 treatment
    Nicolas Ripari, Arthur Alves Sartori, Mariana da Silva Honorio, Fernanda Lopes Conte, Karen Ingrid Tasca, Karina Basso Santiago, José Maurício Sforcin · 2021 · Journal of Pharmacy and Pharmacology
14. SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia
    Ritu Mishra, Akhil Chandra Banerjea · 2021 · Frontiers in Immunology
15. Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19
    Paôline Laurent, Chao Yang, André F. Rendeiro, Benjamin E. Nilsson-Payant, Lucía Carrau, Vasuretha Chandar, Yaron Bram, Benjamin Robert tenOever, Olivier Elemento, Lionel B. Ivashkiv et al. · 2022 · Science Immunology
16. Point-of-care electrochemical testing of biomarkers involved in inflammatory and inflammatory-associated medical conditions
    Diana-Gabriela Macovei, Maria‐Bianca Irimeș, Oana Hosu, Cécilia Cristea, Mihaela Tertiş · 2022 · Analytical and Bioanalytical Chemistry
17. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs
    Brandon Malone, Boris Simovski, Clément Moliné, Jun Cheng, Marius Gheorghe, Hugues Fontenelle, Ioannis Vardaxis, Simen Tennøe, J-A Malmberg, Richard Stratford et al. · 2020 · Scientific Reports
18. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
    Martina Severa, Roberta A. Diotti, Marilena Paola Etna, Fabiana Rizzo, Stefano Fiore, Daniela Ricci, Marco Iannetta, Alessandro Sinigaglia, Alessandra Lodi, Nicasio Mancini et al. · 2021 · PLoS Pathogens
19. Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis
    Huang Kai, Catherine Wang, Christen L. Vagts, Vanitha Raguveer, Patricia W. Finn, David L. Perkins · 2022 · PLoS ONE
20. COVID-19 and pneumonia: a role for the uPA/uPAR system
    Daniele D’Alonzo, Maria De Fenza, Vincenzo Pavone · 2020 · Drug Discovery Today
21. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
    Vincenzo Montesarchio, Roberto Parrella, Chiara Iommelli, Antonella Bianco, Elio Manzillo, Fiorentino Fraganza, Cristiana Palumbo, Gaetano Rea, Patrizia Murino, Rosanna Carmela De Rosa et al. · 2020 · Journal for ImmunoTherapy of Cancer
22. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies
    Praveen Mathews Varghese, Anthony George Tsolaki, Hadida Yasmin, Abhishek Shastri, Janez Ferluga, Manu Vatish, Taruna Madan, Uday Kishore · 2020 · Immunobiology
23. COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
    Valamla Bhavana, Pradip Thakor, Shashi Bala Singh, Neelesh Kumar Mehra · 2020 · Life Sciences
24. Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes
    Seong Woo Choi, Jin Soo Shin, Soon‐Jung Park, Eunhye Jung, Yun-Gwi Park, Jiho Lee, Sung Joon Kim, Hun‐Jun Park, Jung‐Hoon Lee, Sung‐Min Park et al. · 2020 · Antiviral Research
25. A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2
    Ankit Rishi Gupta, Anjali Anand, Neha Jain, Sandeep Goswami, Anbalagan Anantharaj, Sharanabasava Patil, Rahul Singh, Amit Kumar, Tripti Shrivastava, Shinjini Bhatnagar et al. · 2021 · Molecular Therapy — Nucleic Acids
26. High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care
    Nina R. Goldman, Douglas Fink, James Cai, Yun-Ni Lee, Zoe Davies · 2020 · Diabetes Research and Clinical Practice
27. Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
    Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi, Babak Sharif-Kashani, Mohsen Farrokhpour, Hooman Bakhshandeh, Seyed Hashem Sezavar, Ali Dabbagh, Mohammad Taghi Beigmohammadi, Pooya Payandemehr et al. · 2020 · Thrombosis Research
28. Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model
    Q. Lian, Kui-Hua Zhang, Zhao Zhang, Fu-Yu Duan, Li-Yan Guo, Wei-Ren Luo, Bo-Bo W. Mok, A. Thakur, Xiaoshan Ke, Pedram Motallebnejad et al. · 2022 · Nature Communications
29. Potential neurological effects of severe COVID-19 infection
    Domenico Nuzzo, Pasquale Picone · 2020 · Neuroscience Research
30. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation
    Alireza Paniri, Haleh Akhavan‐Niaki · 2020 · Life Sciences
31. Four months into the COVID-19 pandemic, Sweden’s prized herd immunity is nowhere in sight
    Eric J W Orlowski, David J.A. Goldsmith · 2020 · Journal of the Royal Society of Medicine
32. Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study
    Abdullah Balkhair, Ibrahim S Al-Zakwani, Mohammed Al Busaidi, A. Al-Khirbash, Saif Al Mubaihsi, H. BaTaher, Jamal Al Aghbari, I. Al Busaidi, Mahmood A. Al Kindi, Saleh Baawain et al. · 2020 · International Journal of Infectious Diseases
33. Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
    Cole J. Batty, Mark T. Heise, Eric M. Bachelder, Kristy M. Ainslie · 2020 · Advanced Drug Delivery Reviews
34. Testicular Atrophy and Hypothalamic Pathology in COVID-19: Possibility of the Incidence of Male Infertility and HPG Axis Abnormalities
    Kaviya Selvaraj, Sowbarnika Ravichandran, Sushmita Krishnan, Risna Kanjirassery Radhakrishnan, Nivethitha Manickam, Mahesh Kandasamy · 2021 · Reproductive Sciences
35. Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air–Liquid Interface Cultured Human Primary Bronchial Epithelial Cells
    Bram M. ter Ellen, Nilima Dinesh Kumar, Ellen M. Bouma, Berit Troost, Denise P.I. van de Pol, Heidi H. van der Ende-Metselaar, Leonie Apperloo, Djoke van Gosliga, Maarten van den Berge, Martijn C. Nawijn et al. · 2021 · Viruses
36. Implication of COVID-19 on Erythrocytes Functionality: Red Blood Cell Biochemical Implications and Morpho-Functional Aspects
    Annamaria Russo, Ester Tellone, Davide Barreca, Silvana Ficarra, Giuseppina Laganà · 2022 · International Journal of Molecular Sciences
37. Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization
    Taketoshi Mizutani, Aya Ishizaka, Michiko Koga, Kazuhiko Ikeuchi, Makoto Saito, Eisuke Adachi, Seiya Yamayoshi, Kiyoko Iwatsuki‐Horimoto, Atsuhiro Yasuhara, Hiroshi Kiyono et al. · 2022 · Microbiology Spectrum
38. The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?
    Julio Villena, Haruki Kitazawa · 2020 · Frontiers in Physiology
39. Study of COVID-19 pandemic in London (UK) from urban context
    Aritra Ghosh, Srijita Nundy, Sumedha Ghosh, Tapas Kumar Mallick · 2020 · Cities
40. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples
    Livia Mazzini, Donata Martinuzzi, Inesa Hyseni, Linda Benincasa, Eleonora Molesti, Elisa Casa, Giulia Lapini, Pietro Piu, Claudia Maria Trombetta, Serena Marchi et al. · 2020 · Journal of Immunological Methods
41. Vitamin D Status Is Associated With In-Hospital Mortality and Mechanical Ventilation: A Cohort of COVID-19 Hospitalized Patients
    Angeliki M. Angelidi, Matthew J. Belanger, Michael K. Lorinsky, Dimitrios Karamanis, Natalia Chamorro-Pareja, Jennifer Ognibene, Leonidas Palaiodimos, Christos Socrates Mantzoros · 2021 · Mayo Clinic Proceedings
42. Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis
    Giuseppe Fiorentino, Antonietta Coppola, Raffaele Izzo, Anna Annunziata, Mariano Bernardo, Angela Lombardi, Valentina Trimarco, Gaetano Santulli, Bruno Trimarco · 2021 · EClinicalMedicine
43. Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy
    Su Zhang, Yang Meng, Lian Zhou, Lei Qiu, Heping Wang, Dan Su, Bo Zhang, Kui Ming Chan, Junhong Han · 2022 · MedComm
44. COVID-19 Associated Invasive Pulmonary Aspergillosis: Diagnostic and Therapeutic Challenges
    Aia Mohamed, Thomas Richard Rogers, Alida Fe Talento · 2020 · Journal of Fungi
45. Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection
    Abdulrahman Algassim, Assem Elghazaly, Abdulrahman S. Alnahdi, Owais Mohammed Rahim, Abdulaziz G. Alanazi, Nawaf A. Aldhuwayhi, Mashael Musnad Odhayb Alanazi, Mohammed F. Almutairi, Ibrahim Mohammed Aldeailej, Najeeb A. Kamli et al. · 2020 · Annals of Hematology
46. COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities
    Nathalie Chavarot, Juliette Gueguen, Guillaume Bonnet, Mariam Jdidou, Antonin Trimaille, Carole Burger, Lucile Amrouche, Orianne Weizman, Thibaut Pommier, Olivier Aubert et al. · 2020 · American Journal of Transplantation
47. COVID-19 in ocrelizumab-treated people with multiple sclerosis
    Richard A. Hughes, Louise Whitley, Kocho Fitovski, Hans‐Martin Schneble, Erwan Muros‐Le Rouzic, Annette Sauter, Licínio Craveiro, Paul Dillon, Ulrike Bonati, Nikki Jessop et al. · 2020 · Multiple Sclerosis and Related Disorders
48. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
    Corleone S. Delaveris, Aaron J. Wilk, Nicholas McIlvain Riley, Jessica C. Stark, Samuel S. Yang, Angela J. Rogers, Thanmayi Ranganath, Kari Christine Nadeau, The Stanford COVID-19 Biobank, Catherine A. Blish et al. · 2021 · ACS Central Science
49. ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma
    Peter A. B. Wark, Prabuddha S. Pathinayake, Gerard E. Kaiko, Kristy Nichol, Ayesha Ali, Ling Chen, Erika N. Sutanto, Luke W. Garratt, Sukhwinder Singh Sohal, Wenying Lu et al. · 2021 · Respirology
50. Relationship between blood eosinophil levels and COVID-19 mortality
    Bingdi Yan, Junling Yang, Yan Xie, Xiaolei Tang · 2021 · World Allergy Organization Journal
51. Monitoring of SARS‐CoV‐2 infection in mustelids
    A. Boklund, C. Gortázar, P. Pasquali, H. Roberts, S. Nielsen, K. Ståhl, A. Stegeman, Francesca Baldinelli, A. Broglia, Y. Van der Stede et al. · 2021 · EFSA journal. European Food Safety Authority
52. Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19
    Anno Saris, Tom D. Y. Reijnders, Esther J. Nossent, Alex R. Schuurman, Jan Verhoeff, Saskia D. van Asten, Hetty J. Bontkes, Siebe G. Blok, JanWillem Duitman, Harm Jan Bogaard et al. · 2021 · Thorax
53. Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review
    Garyfallia Pepera, Marina-Sofia Tribali, Ladislav Baťalík, Ivo Spasov Petrov, Jannis Vasileios Papathanasiou · 2022 · Reviews in Cardiovascular Medicine
54. Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review
    Swarnali Das, Suvrendu Sankar Kar, Sovan Samanta, Jhimli Banerjee, Biplab Giri, Sandeep Kumar Dash · 2022 · Immunologic Research
55. Regulation of the alveolar regenerative niche by amphiregulin-producing regulatory T cells
    Kaiser, Katherine A., Loffredo, Lucas F., Santos-Alexis, Kenia de los, Ringham, Olivia R., Arpaia, Nicholas · 2023 · Journal of Experimental Medicine
56. Pneumonia-Induced Inflammation, Resolution and Cardiovascular Disease: Causes, Consequences and Clinical Opportunities
    Cameron Stotts, Vicente Corrales‐Medina, Katey J. Rayner · 2023 · Circulation Research
57. Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
    Xingpeng Di, Ya Li, Jingwen Wei, Tianyue Li, Banghua Liao · 2024 · Advanced Science
58. Coronavirus Optimization Algorithm: A Bioinspired Metaheuristic Based on the COVID-19 Propagation Model
    Martínez Álvarez, Francisco, Asencio Cortés, Gualberto, José Francisco Torres, Gutiérrez Avilés, David, Melgar García, Laura, Pérez Chacón, R., Rubio Escudero, Cristina, Riquelme Santos, José Cristóbal, Troncoso Lora, Alicia · 2020 · idUS (Universidad de Sevilla)
59. SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity
    Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo, Maria Grazia Cusi · 2021 · Viruses
60. COVID-19, Acute Myocardial Injury, and Infarction
    Armando Del Prete, Francesca M. Conway, Domenico Giovanni Della Rocca, Giuseppe Biondi‐Zoccai, Francesco De Felice, Carmine Musto, Marco Picichè, Eugenio Martuscelli, Andrea Natale, Francesco Versaci · 2021 · Cardiac Electrophysiology Clinics
61. Diagnostic value of lactate dehydrogenase in COVID-19: A systematic review and meta-analysis
    Bartosz Fialek, Michał Pruc, Jacek Smereka, Rafal Jas, Mansur Rahnama, Andrea Denegri, Agnieszka Szarpak, Milosz Jaroslaw Jaguszewski, Frank William Peacock, Łukasz Szarpak · 2022 · Cardiology Journal
62. Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19
    Caspar I. van der Made, Mihai Gheorghe Netea, Frank L. van de Veerdonk, Alexander Hoischen · 2022 · Genome Medicine
63. Clinical trial to test the efficacy of melatonin in COVID‐19
    Darı́o Acuña-Castroviejo, Germaine Escames, Juan Carlos Figueira, Pedro de la Oliva, Alberto Manuel Borobia, Carlos Acuña‐Fernández · 2020 · Journal of Pineal Research
64. Severe COVID-19: what have we learned with the immunopathogenesis?
    Bruno Bordallo Corrêa, Mozart Bellas Rodrigues, Arthur Fernandes Cortez, Matheus Vieira, Marcelo M. Pinheiro · 2020 · Revista Brasileira de Reumatologia
65. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients
    Didier M. Payen, Maxime Cravat, Hadil Maadadi, Carole Didelot, Lydia Prosic, Claire Dupuis, Marie-Reine Losser, Marcelo De Carvalho Bittencourt · 2020 · Frontiers in Immunology
66. Sleep and COVID-19: considerations about immunity, pathophysiology, and treatment.
    2020 · PubMed Central
67. Socio-demographic and health factors drive the epidemic progression and should guide vaccination strategies for best COVID-19 containment
    Rene Markovič, Marko Šterk, Marko Marhl, Matjaž Perc, Marko Gosak · 2021 · Results in Physics
68. Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents
    Nina Koerber, Alina Priller, Sarah Yazici, Tanja Bauer, Cho‐Chin Cheng, Hrvoje Mijočević, Hannah Wintersteller, Samuel D. Jeske, Emanuel Vogel, Martin Feuerherd et al. · 2022 · Nature Communications
69. Hematopoietic responses to SARS-CoV-2 infection
    Shokrollah Elahi · 2022 · Cellular and Molecular Life Sciences
70. The Role of Macrophages and Alveolar Epithelial Cells in the Development of ARDS
    Huan Qi Tao, Younian Xu, Shihai Zhang · 2022 · Inflammation
71. Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS‐CoV ‐2s
    Aniza Puteri Mahyuddin, Abhiram Kanneganti, Jeslyn Jing Lin Wong, Pooja Sharma Dimri, Lin Su, Arijit Biswas, Sebastian Enrique Illanes, Citra Nurfarah Zaini Mattar, Ruby Yun‐Ju Huang, Mahesh Arjandas Choolani · 2020 · Prenatal Diagnosis
72. Diabetes and COVID-19: Global and regional perspectives
    In‐Kyung Jeong, Kun‐Ho Yoon, Moon Kyu Lee · 2020 · Diabetes Research and Clinical Practice
73. SARS‐CoV‐2, COVID‐19, skin and immunology – What do we know so far?
    Natalijia Novak, Wenming Peng, Mirjam Nägeli, Christina Galvan, Isabel Kolm‐Djamei, Marie‐Charlotte Brüggen, Beatriz Cabanillas, Peter Schmid‐Grendelmeier, Alba Català · 2020 · Allergy
74. Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives
    Iqbal Mahmud, Timothy J. Garrett · 2020 · Journal of the American Society for Mass Spectrometry
75. Severe COVID-19 Lung Infection in Older People and Periodontitis
    Rubén Aquino-Martínez, Scarlette Hernández Vigueras · 2021 · Journal of Clinical Medicine
76. Viral coinfections in COVID‐19
    Parisa Shiri Aghbash, Narges Eslami, Milad Shirvaliloo, Hossein Bannazadeh Baghi · 2021 · Journal of Medical Virology
77. Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization
    Ayman Abo Elmaaty, Mohammed I. A. Hamed, Muhammad I. Ismail, Eslam B. Elkaeed, Hamada S. Abulkhair, Muhammad Khattab, Ahmed Ali Al-Karmalawy · 2021 · Molecules
78. The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies
    Shilei Zhang, Lulan Wang, Genhong Cheng · 2022 · Molecular Therapy
79. The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infection
    Muhammad Suhaib Qudus, Mingfu Tian, Summan Sirajuddin, Siyu Liu, Uzair Afaq, Muneeba Wali, Jinbiao Liu, Pan Pan, Zhen Luo, Qiwei Zhang et al. · 2023 · Journal of Medical Virology
80. Immunotherapeutic approaches to curtail COVID-19
    Hajar Owji, Manica Negahdaripour, Nasim Hajighahramani · 2020 · International Immunopharmacology
81. Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers
    Margherita Bruni, Valentina Cecatiello, Angélica Díaz‐Basabe, Georgia Lattanzi, Erika Mileti, Silvia Monzani, Laura Pirovano, Francesca Rizzelli, Clara Visintin, Giuseppina Bonizzi et al. · 2020 · Journal of Clinical Medicine
82. SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression
    Artem A. Nemudryi, Anna Nemudraia, Tanner Wiegand, Joseph E. Nichols, Deann Teresa Snyder, Jodi F. Hedges, Calvin Cicha, Helen Lee, Karl K. Vanderwood, Diane Bimczok et al. · 2021 · Cell Reports
83. Viral Myocarditis—From Pathophysiology to Treatment
    Schultheiss, Heinz-Peter, Baumeier, Christian, Aleshcheva, Ganna, Bock, C.-Thomas, Escher, Felicitas · 2021 · Journal of Clinical Medicine
84. Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome
    Qin Liu, Qi Su, Fen Zhang, Hein Min Tun, Joyce Wing Yan Mak, Grace Chung-Yan Lui, Susanna S. Ng, Jessica Y. L. Ching, Wenqi Lu, Wenqi Lu et al. · 2022 · Nature Communications
85. New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine
    Hanli Xu, Shuye Lin, Ziyun Zhou, Duoduo Li, Xiting Zhang, Muhan Yu, Ruoyi Zhao, Yiheng Wang, Junru Qian, Xinyi Li et al. · 2023 · Cellular and Molecular Immunology
86. Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review
    Malavika Lingeswaran, Taru Goyal, Raghumoy Ghosh, Smriti Suri, Prasenjit Mitra, Sanjeev Misra, Praveen Sharma · 2020 · Indian Journal of Clinical Biochemistry
87. Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response
    Md. Abdul Hannan, Md. Ataur Rahman, Md Saidur Rahman, Abdullah Al Mamun Sohag, Raju Dash, Khandkar Shaharina Hossain, Mithila Farjana, Md Jamal Uddin · 2020 · Immunology Letters
88. Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers
    Mai Mahmoud Zafer, Hadir A. El‐Mahallawy, Hossam M. Ashour · 2021 · Microorganisms
89. Macrophage Responses to Environmental Stimuli During Homeostasis and Disease
    Adil Rasheed, Katey J. Rayner · 2021 · Endocrine Reviews
90. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes
    Lucy MacDonald, Stefano Alivernini, Barbara Tolusso, Aziza Elmesmari, Domenico Somma, Simone Perniola, Annamaria Paglionico, Luca Petricca, Silvia Laura Bosello, Angelo Carfì et al. · 2021 · JCI Insight
91. COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge
    Anna Furlan, Gabriella Forner, Ludovica Cipriani, Elisa Vian, Roberto Rigoli, Filíppo Gherlinzoni, Piergiorgio Scotton · 2021 · Frontiers in Immunology
92. Mechanisms underpinning poor antibody responses to vaccines in ageing
    Jia Le Lee, Michelle A. Linterman · 2021 · Immunology Letters
93. COVCOG 1: Factors Predicting Physical, Neurological and Cognitive Symptoms in Long COVID in a Community Sample. A First Publication From the COVID and Cognition Study
    Panyuan Guo, Álvaro Benito-Ballesteros, Sabine P. Yeung, Ruby Liu, Arka Saha, Lyn Curtis, Muzaffer Kaşer, Mark P. Haggard, Lucy G. Cheke · 2022 · Frontiers in Aging Neuroscience
94. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium
    Neal G. Ravindra, Mia Madel Alfajaro, Victor Gasque, Victoria Habet, Jin Wei, Renata B. Filler, Nicholas C. Huston, Han Wan, Klara Szigeti-Buck, Bao Wang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
95. Outcomes from COVID-19 across the range of frailty: excess mortality in fitter older people
    Amy Miles, Thomas E. Webb, Benjamin C. Mcloughlin, Imran Mannan, Arshad Rather, Paul Knopp, Daniel H J Davis · 2020 · European Geriatric Medicine
96. Complementary regulation of caspase-1 and IL-1β reveals additional mechanisms of dampened inflammation in bats
    Geraldine Goh, Matae Ahn, Feng Zhu, Lim Beng Lee, Dahai Luo, Aaron Trent Irving, Lin‐Fa Wang · 2020 · Proceedings of the National Academy of Sciences
97. Remdesivir: From Ebola to COVID-19
    M. Gabriella Santoro, Ernesto Carafoli · 2020 · Biochemical and Biophysical Research Communications
98. TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target
    Gillina F. G. Bezemer, Johan Garssen · 2021 · Frontiers in Pharmacology
99. The impact of oral health status on COVID-19 severity, recovery period and C-reactive protein values
    Amany Hany Mohamed Kamel, Ahmed Basuoni, Zeinab Amin Salem, Nermeen AbuBakr · 2021 · BDJ
100. EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection
     Mukesh Chourasia, Purushotham Reddy Koppula, Aruna Battu, Madhu Micheal Ouseph, Anil Singh · 2021 · Molecules